Mavacamten, also known as SAR-439152 and MYK-461, is the first (first-in-class) oral bioavailability of an allosteric and reversible selective inhibitor of cardiac myosin. It can regulate the sarcomere contraction of hypertrophic cardiomyopathy, and the
Molekulargewicht:
273.33
Reinheit:
99.80%
CAS Nummer:
[1642288-47-8]
Formel:
C15H19N3O2
Target-Kategorie:
Myosin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten